Hood River Capital Management’s Verona Pharma VRNA Stock Holding History

Hood River Capital Management’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-18,882	Closed	-$2.01M	–	193
2025 Q3	$2.01M	Sell	18,882 -1,543,585	-99%	-$161M	0.02%	143
2025 Q2	$148M	Buy	1,562,467 +30,119	+2%	+$2.23M	2.06%	8
2025 Q1	$97.3M	Buy	1,532,348 +47,092	+3%	+$2.82M	1.66%	9
2024 Q4	$69M	Buy	1,485,256 +51,322	+4%	+$1.93M	1.02%	36
2024 Q3	$41.3M	Buy	1,433,934 +371,478	+35%	+$9.14M	0.67%	61
2024 Q2	$15.4M	Buy	1,062,456 +74,700	+8%	+$1.09M	0.32%	90
2024 Q1	$15.9M	Buy	987,756 +41,154	+4%	+$712K	0.35%	83
2023 Q4	$18.8M	Buy	+946,602	New	+$14M	0.52%	67

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Hood River Capital Management's VRNA Position: Q4 2025 in Review

Hood River Capital Management sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 18,882 shares — an estimated $2.01M sold.

Hood River Capital Management first reported a position in VRNA in Q4 2023 and held it in 8 quarters. The position peaked at $148M in Q2 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Hood River Capital Management reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Hood River Capital Management sold 18,882 Verona Pharma shares in Q4 2025, an estimated $2.01M.
Hood River Capital Management first reported a position in Verona Pharma in Q4 2023 and held it in 8 quarters.
Hood River Capital Management's Verona Pharma position peaked at $148M in Q2 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Hood River Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.